ICAM4 (NM_001039132) Human Mass Spec Standard

CAT#: PH300636

ICAM4 MS Standard C13 and N15-labeled recombinant protein (NP_001034221)



  View other "ICAM4" proteins (8)

Need it in bulk or customized?
Get a free quote

CNY 19,520.00


货期*
4周

规格
    • 10 ug

Product images

经常一起买 (2)
Rabbit Polyclonal Anti-ICAM4 Antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00


Transient overexpression lysate of intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) (ICAM4), transcript variant 2
    • 100 ug

CNY 3,080.00

Specifications

Product Data
Description ICAM4 MS Standard C13 and N15-labeled recombinant protein (NP_001034221)
Species Human
Expression Host HEK293
Expression cDNA Clone or AA Sequence RC200636
Predicted MW 29.6 kDa
Protein Sequence
Tag C-Myc/DDK
Purity > 80% as determined by SDS-PAGE and Coomassie blue staining
Concentration >0.05 µg/µL as determined by microplate BCA method
Labeling Method Labeled with [U- 13C6, 15N4]-L-Arginine and [U- 13C6, 15N2]-L-Lysine
Buffer 25 mM Tris-HCl, 100 mM glycine, pH 7.3
Reference Data
RefSeq NP_001034221
RefSeq Size 1277
RefSeq ORF 816
Synonyms CD242; LW
Locus ID 3386
Cytogenetics 19p13.2
Summary This gene encodes the Landsteiner-Wiener (LW) blood group antigen(s) that belongs to the immunoglobulin (Ig) superfamily, and that shares similarity with the intercellular adhesion molecule (ICAM) protein family. This ICAM protein contains 2 Ig-like C2-type domains and binds to the leukocyte adhesion LFA-1 protein. The molecular basis of the LW(A)/LW(B) blood group antigens is a single aa variation at position 100; Gln-100=LW(A) and Arg-100=LW(B). Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]
Protein Families Secreted Protein, Transmembrane
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...